Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Lymphoma

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

Leukemia volume 15, pages 1123–1126 (2001)Cite this article

Abstract

Nasal NK/T cell is a rare form of usually localized non-Hodgkin's lymphoma (NHL) which generally carries a poor prognosis when treated with conventional NHL chemotherapy protocols. We reviewed 20 consecutive localized stage I/II nasal NK/T cell lymphomas treated at our institution over a 29 year period. Median age was 44 (range 23–71). Front-line therapy was generally radiotherapy alone (35–70 Gy) before 1980 and combination chemotherapy after 1980. Six patients were treated with first-line radiotherapy and they achieved complete remission (CR). Two subsequently received combination chemotherapy. Five of those patients remained in complete remission, after 97+ to 277+ months. Twelve patients were treated with first-line chemotherapy including CHOP or CHOP-like regimen in seven cases, and COP in five cases. Only three of them achieved CR, five had partial response and four had progressive disease. Five of the seven patients treated with CHOP did not achieve complete remission. The nine patients who failed to achieve CR with chemotherapy subsequently received salvage radiotherapy but only two of them obtained CR. Finally, two patients were treated with alternated chemotherapy and radiotherapy and achieved CR, which persisted after 14+ and 26+ months. Median survival was not reached in patients who received front-line radiotherapy, and was 35 months in patients who received front-line chemotherapy. These findings confirm that chemotherapy gives a low complete remission rate in localized nasal NK/T cell lymphoma. By contrast, first-line radiotherapy seems to give favorable results, whereas its results are poorer when administered after resistance to chemotherapy. Whether the use of chemotherapy after radiotherapy, or alternated chemotherapy–radiotherapy regimens give better clinical results than radiotherapy alone will have to be evaluated prospectively in this type of NHL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PTM, Ng CS, Ngan RKC . Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype and treatment outcome in 113 patients J Clin Oncol 1998 16: 70–77

    Article  CAS  PubMed  Google Scholar 

  2. Ferry J, Sklar J, Zukerberg LR, Harris NL . Nasal lymphoma. A clinicopathologic study with immunophenotype and genotypic analysis Am J Surg Pathol 1991 15: 268–279

    Article  CAS  PubMed  Google Scholar 

  3. Kwong YL, Chan ACL, Liang RHS . Natural killer lymphoma/leukemia pathology and treatment Hematol Oncol 1997 15: 71–79

    Article  CAS  PubMed  Google Scholar 

  4. Kanavaros P, Lescs M-L, Brière J, Divine M, Galateau F, Joab I, Bosq J, Farcet J-P, Reyes F, Gaulard P . Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein–Barr virus Blood 1993 81: 2688–2695

    CAS  PubMed  Google Scholar 

  5. Emile J-F, Boulland M-L, Haioun C, Kanavaros P, Petrella T, Delfau-Larue M-H, Bensussan A, Farcet J-P, Gaulard P . CD5−CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas Blood 1996 87: 1466–1473

    CAS  PubMed  Google Scholar 

  6. Cheze S, Gaulard P, Molina S, Moullet I, Quesnel B, Petrella T, Baglin AC, Diebold J, Reyes F, Gisselbrecht C, Leporrier M . Clinicopathologic study of 27 T/natural killer cell lymphomas of the nasal cavity and paranasal sinuses from the GELA protocols Blood 1999 94 (Suppl. 1): 516a

    Google Scholar 

  7. Kwong YL, Chan ACL, Liang R, Chiang AKS, Chim CS, Chan TK . CD56+ NK lymphomas: clinicopathological features and prognosis Br J Haematol 1997 97: 821–829

    Article  CAS  PubMed  Google Scholar 

  8. Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, Chay D, Ho FCS . Treatment outcome and prognosis factors for primary nasal lymphoma J Clin Oncol 1995 13: 666–670

    Article  CAS  PubMed  Google Scholar 

  9. Li Y-X, Coucke PA, Li J-Y, Gu D-Z, Liu X-F, Zhou Z-Q, Mirimanoff R-O, Yu Z-H, Huang Y-R . Primary non-Hodgkin's lymphoma of the nasal cavity. Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy Cancer 1998 83: 449–456

    Article  CAS  PubMed  Google Scholar 

  10. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, Hong WP, Park Y, Hahn JS, Roh JK, Kim BS . Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiotherapy alone J Clin Oncol 2000 18: 54–63

    Article  CAS  PubMed  Google Scholar 

  11. The international non-Hodgkin's lymphoma prognostic factors project . A predictive model for aggrressive non-Hodgkin's lymphoma N Engl J Med 1993 329: 987–994

    Article  Google Scholar 

  12. Drénou B, Lamy T, Amiot L, Fardel O, Caulet-Maugendre S, Sasportes M, Diebold J, Le Prisé P-Y, Fauchet R . CD3−CD56+non-Hodgkin's lymphomas with an aggressive behavior related tomultidrug resistance Blood 1997 8: 2966–2974

    Google Scholar 

Download references

Author information

Author notes

  1. P Fenaux and J Bosq: PF and JB contributed equally as last authors to this work

Authors and Affiliations

  1. Département de Médecine, Institut Gustave-Roussy, Villejuif, France

    V Ribrag, MEll Hajj, C Domenge, G Schwaab & P Fenaux

  2. Département de Chirurgie Cervico Faciale, Institut Gustave-Roussy, Villejuif, France

    F Janot & T Girinsky

  3. Département de Radiothérapie, Institut Gustave-Roussy, Villejuif, France

    P Fenaux

  4. Département de Pathologie, Institut Gustave-Roussy, Villejuif, France

    J Bosq

Authors
  1. V Ribrag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MEll Hajj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Janot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Girinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Domenge
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Schwaab
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P Fenaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J Bosq
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribrag, V., Hajj, M., Janot, F. et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 15, 1123–1126 (2001). https://doi.org/10.1038/sj.leu.2402148

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402148

Keywords

This article is cited by

Search

Advanced search

Quick links